Nobuhiro Yamada Selected Research

Nobuhiro Yamada Research Topics

Disease

26	Insulin Resistance 01/2018 - 05/2002
19	Type 2 Diabetes Mellitus (MODY) 01/2017 - 10/2002
19	Obesity 07/2014 - 05/2002
16	Atherosclerosis 01/2021 - 01/2002
9	Hypertriglyceridemia 01/2016 - 05/2002
9	Hypertension (High Blood Pressure) 04/2012 - 09/2002
8	Diabetes Complications 10/2014 - 08/2007
7	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2002
7	Dyslipidemias (Dyslipidemia) 04/2012 - 10/2002
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2013 - 12/2006
5	Inflammation (Inflammations) 01/2018 - 12/2012
5	Hypercholesterolemia 11/2016 - 01/2002
5	Stroke (Strokes) 12/2013 - 09/2002
5	Hyperglycemia 03/2012 - 12/2003
4	Fatty Liver 12/2015 - 12/2003
4	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2013 - 08/2002
4	Neoplasms (Cancer) 01/2013 - 07/2003
4	Diabetes Mellitus 07/2012 - 01/2004
4	Abdominal Obesity 11/2010 - 08/2006
3	Fibrosis (Cirrhosis) 01/2018 - 11/2004
3	Weight Loss (Weight Reduction) 01/2013 - 09/2007
3	Hyperinsulinism (Hyperinsulinemia) 06/2005 - 12/2003
2	Non-alcoholic Fatty Liver Disease 07/2017 - 01/2016
2	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 12/2003
2	Rhabdomyolysis 10/2015 - 10/2007
2	Muscular Diseases (Myopathy) 10/2015 - 10/2007
2	Body Weight (Weight, Body) 12/2014 - 01/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2014 - 12/2007
2	Hypertrophy 07/2014 - 07/2008
2	Coronary Disease (Coronary Heart Disease) 05/2012 - 11/2011
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 07/2009 - 01/2008
2	Glucose Intolerance 01/2009 - 08/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2008 - 01/2005
2	Vascular Diseases (Vascular Disease) 02/2008 - 01/2004
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2004 - 03/2002
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2004 - 01/2003
1	Lipodystrophy 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Alcoholic Fatty Liver 01/2016
1	Gallstones (Gallstone) 12/2015

Drug/Important Bio-Agent (IBA)

19	Triglycerides (Triacylglycerol)IBA 01/2013 - 10/2002
18	HDL CholesterolIBA 05/2013 - 05/2002
17	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2004
17	LipidsIBA 01/2018 - 01/2002
13	CholesterolIBA 11/2016 - 01/2002
11	LDL CholesterolIBA 04/2012 - 01/2002
11	Insulin (Novolin)FDA Link 09/2009 - 01/2002
9	Sterol Regulatory Element Binding Protein 1IBA 01/2018 - 09/2003
8	Fatty Acids (Saturated Fatty Acids)IBA 07/2017 - 12/2003
7	Lipoproteins (Lipoprotein)IBA 01/2021 - 05/2002
7	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2012 - 05/2002
6	EnzymesIBA 01/2016 - 05/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 01/2002
6	oxidized low density lipoproteinIBA 01/2013 - 10/2002
6	Messenger RNA (mRNA)IBA 01/2010 - 05/2002
5	Proteins (Proteins, Gene)FDA Link 01/2013 - 11/2002
5	SterolsIBA 08/2011 - 05/2002
5	ElementsIBA 08/2011 - 05/2002
5	LeptinIBA 09/2009 - 05/2002
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2003
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 03/2013 - 06/2004
4	LDL Lipoproteins (beta Lipoproteins)IBA 04/2012 - 10/2002
3	CreatinineIBA 05/2013 - 12/2009
3	AlbuminsIBA 05/2013 - 12/2009
3	LDL Receptors (LDL Receptor)IBA 09/2011 - 01/2004
3	Fatty Acid ElongasesIBA 09/2011 - 10/2007
3	pitavastatin (itavastatin)FDA Link 10/2002 - 01/2002
2	Apolipoproteins B (ApoB)IBA 01/2021 - 06/2004
2	Oleic Acid (Oleate)IBA 01/2017 - 12/2015
2	PalmitatesIBA 01/2017 - 12/2012
2	Hemoglobins (Hemoglobin)IBA 10/2014 - 03/2013
2	Monounsaturated Fatty AcidsIBA 07/2014 - 09/2011
2	Dietary Fiber FDA Link 12/2013 - 03/2013
2	AntioxidantsIBA 03/2013 - 01/2006
2	ORALIT (ORS)IBA 01/2013 - 10/2011
2	Sterol Regulatory Element Binding ProteinsIBA 12/2012 - 12/2003
2	Blood Glucose (Blood Sugar)IBA 07/2012 - 01/2012
2	HDL LipoproteinsIBA 04/2012 - 01/2012
2	GlycogenIBA 04/2012 - 04/2004
2	BezafibrateIBA 03/2012 - 10/2007
2	Pharmaceutical PreparationsIBA 08/2010 - 08/2009
2	ProstaglandinsIBA 08/2010 - 09/2008
2	Rosuvastatin Calcium (Crestor)FDA Link 10/2007 - 01/2002
2	Insulin Receptor Substrate ProteinsIBA 10/2007 - 04/2004
2	Sorbitol (Yal)FDA Link 11/2004 - 03/2002
2	low density lipoprotein inhibitorIBA 07/2004 - 06/2004
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 04/2004 - 08/2002
2	PPAR alphaIBA 12/2003 - 05/2002
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2003 - 06/2002
1	PhosphoenolpyruvateIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2017
1	Docosahexaenoic AcidsIBA 01/2016
1	Transaminases (Aminotransferases)IBA 01/2016
1	Co-Repressor ProteinsIBA 01/2016
1	Eicosapentaenoic AcidIBA 01/2016
1	Choline (Choline Chloride)IBA 01/2016
1	Methionine (L-Methionine)FDA Link 01/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016

Therapy/Procedure

5	Glycemic Control 04/2012 - 11/2002
3	Therapeutics 11/2004 - 01/2003